Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Pharma
Asia
Drug Delivery
Executives
Clinical Data
Vaccines
Special Reports
Trending
COVID-19
Cell & Gene Therapy
Podcasts
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Subscribe
Subscribe
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Pharma
Asia
Drug Delivery
Executives
Clinical Data
Vaccines
Special Reports
Trending
COVID-19
Cell & Gene Therapy
Podcasts
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
Lynparza
Pharma
AZ's Imfinzi-Lynparza combo adds endometrial cancer trial win
AZ's positive readout comes shortly after GSK’s Jemperli and Merck’s Keytruda celebrated their own triumphs in first-line endometrial cancer.
Angus Liu
May 26, 2023 10:28am
FDA panel gives Lynparza narrow backing in prostate cancer
Apr 28, 2023 3:51pm
FDA argues Lynparza only works in prostate cancer subset
Apr 26, 2023 3:06pm
'Eligibility challenges' derail GSK's Zejula breast cancer trial
Apr 26, 2023 1:57pm
AZ's Imfinzi-Lynparza will face tough FDA scrutiny: analyst
Apr 6, 2023 11:22am
AZ wins royalties case against GSK over PARP inhibitor Zejula
Apr 5, 2023 7:11pm
